Journal article
Anesthetic Management Using Remifentanil Target-Controlled Infusion for an Infant with Trisomy 13 (Patau's Syndrome) Undergoing Glaucoma Surgery - A Case Report
Anesthesia and Resuscitation, Vol.50(4), pp.85-87
12/20/2014
Abstract
[Introduction] Trisomy 13 (Patau's syndrome) was first described in 1960. It is a rare chromosomal abnormality affecting 1/5,000 live births with a very low life expectancy: median survival is less than 3 months and almost 90% die during the first year. The syndrome is characterized by multiple congenital abnormalities including microcephaly, microphthalmia, cleft lip/palate, holoprosencephaly, myelomeningocele, polydactyly, cardiac defects and genitourinary abnormalities. Because of the poor prognosis of this syndrome, active treatments such as surgical procedures have not usually been performed. There have been only two reports on anesthetic managements for patients with trisomy 13. In this report, anesthetic management using remifentanil target-controlled infusion for an infant with trisomy 13 (two months old) for glaucoma surgery is described. [Case report] A two-month-old male infant was scheduled to undergo trabeculotomy for glaucoma. His weight was 3,700 g. He was born in the 37th gestational week with a birth weight of 2,798 g.
Details
- Title: Subtitle
- Anesthetic Management Using Remifentanil Target-Controlled Infusion for an Infant with Trisomy 13 (Patau's Syndrome) Undergoing Glaucoma Surgery - A Case Report
- Creators
- Daisuke SugiyamaSatoshi TanakaEriko ImaiToshiyuki TanakaSusumu IdeMikito Kawamata
- Resource Type
- Journal article
- Publication Details
- Anesthesia and Resuscitation, Vol.50(4), pp.85-87
- Publisher
- Hiroshima Association of Anesthesiologists
- ISSN
- 0385-1664
- Language
- English; Japanese
- Date published
- 12/20/2014
- Academic Unit
- Anesthesia
- Record Identifier
- 9984787258202771
Metrics
1 Record Views